Teva Reaches Agreement With Florida to Settle the State’s Opioid-Related Claims

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. and its affiliates, has reached an agreement with the Attorney General of Florida that settles the state’s and its subdivisions opioid-related claims. The settlement will provide Florida $177 million over 15 years, as well as life-saving medicine generic Narcan (naloxone hydrochloride nasal spray), valued at $84 million (wholesale acquisition cost), over 10 years.

Today’s settlement with the state of Florida is another critical step forward in getting life-saving treatments to people suffering from opioid addiction. This settlement agreement is not an admission of any liability or wrongdoing, and the Company will continue to defend itself in court in states where we have not reached terms of a settlement agreement.